Surgery Partners, Inc. Stock 12‑Month Price Target Cut to $18.62, Implies 18% Upside

What happened

The average 12-month price target for Surgery Partners stock from 8 analysts fell slightly from $18.78 to $18.62. Based on the Oct. 23 closing price, the new target implies about 18% potential upside.

Confirmed

Global impact / market context

A lower average target means analysts on balance expect a bit less future gain from the stock, though the change is small. The implied 18% upside suggests they still see room to rise from the Oct. 23 close.

Analyst inference

The consensus rating stays "Buy" across 9 analysts, split into 6 Buys and 3 Holds with no Sells. Forecasts range widely from $14 to $24, signaling genuine disagreement among analysts about the company's value.

Analyst inference

What to watch

1. The average target came from 8 analysts and now sits at $18.62, down from $18.78. Individual forecasts span $14 to $24 per share, so watch whether that range narrows. Confirmed
2. Watch whether any of the 9 analysts change their rating, since the current split is 6 Buys, 3 Holds and 0 Sells. A shift toward Holds would weaken the Buy consensus. Proposed
3. Because the target implies roughly 18% upside from the Oct. 23 close, watch the share price: a rising price shrinks that gap, while a falling price widens it. Analyst inference

Evidence

• Original source link unavailable